Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Haldosén L[au]:

Search results

Items: 1 to 50 of 51

1.

Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1.

He H, Song D, Sinha I, Hessling B, Li X, Haldosen LA, Zhao C.

Oncogene. 2019 Apr 23. doi: 10.1038/s41388-019-0824-4. [Epub ahead of print]

PMID:
31015574
2.

Expression of the three components of linear ubiquitin assembly complex in breast cancer.

Kharman-Biz A, Gao H, Ghiasvand R, Haldosen LA, Zendehdel K.

PLoS One. 2018 May 15;13(5):e0197183. doi: 10.1371/journal.pone.0197183. eCollection 2018.

3.

c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer.

He H, Sinha I, Fan R, Haldosen LA, Yan F, Zhao C, Dahlman-Wright K.

Oncogene. 2018 May;37(19):2586-2600. doi: 10.1038/s41388-018-0165-8. Epub 2018 Feb 22.

PMID:
29467493
4.

Estrogen receptor β2 induces proliferation and invasiveness of triple negative breast cancer cells: association with regulation of PHD3 and HIF-1α.

Bialesova L, Xu L, Gustafsson JÅ, Haldosen LA, Zhao C, Dahlman-Wright K.

Oncotarget. 2017 Sep 4;8(44):76622-76633. doi: 10.18632/oncotarget.20635. eCollection 2017 Sep 29.

5.

Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism.

Jia M, Andreassen T, Jensen L, Bathen TF, Sinha I, Gao H, Zhao C, Haldosen LA, Cao Y, Girnita L, Moestue SA, Dahlman-Wright K.

Cancer Res. 2016 Oct 1;76(19):5634-5646. Epub 2016 Jul 25.

6.

Induction of USP17 by combining BET and HDAC inhibitors in breast cancer cells.

Borbely G, Haldosen LA, Dahlman-Wright K, Zhao C.

Oncotarget. 2015 Oct 20;6(32):33623-35. doi: 10.18632/oncotarget.5601.

7.

Diclofenac and triamcinolone acetonide impair tenocytic differentiation and promote adipocytic differentiation of mesenchymal stem cells.

Fredriksson M, Li Y, Stålman A, Haldosén LA, Felländer-Tsai L.

J Orthop Surg Res. 2013 Sep 2;8:30. doi: 10.1186/1749-799X-8-30.

8.

Estrogen receptor beta in breast cancer.

Haldosén LA, Zhao C, Dahlman-Wright K.

Mol Cell Endocrinol. 2014 Jan 25;382(1):665-672. doi: 10.1016/j.mce.2013.08.005. Epub 2013 Aug 15. Review.

9.

MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.

Aydoğdu E, Katchy A, Tsouko E, Lin CY, Haldosén LA, Helguero L, Williams C.

Carcinogenesis. 2012 Aug;33(8):1502-11. doi: 10.1093/carcin/bgs161. Epub 2012 May 4.

PMID:
22562546
10.

Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.

Lindberg K, Helguero LA, Omoto Y, Gustafsson JÅ, Haldosén LA.

Breast Cancer Res. 2011 Apr 14;13(2):R43. doi: 10.1186/bcr2865.

11.

Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.

Lindberg K, Ström A, Lock JG, Gustafsson JA, Haldosén LA, Helguero LA.

J Cell Physiol. 2010 Jan;222(1):156-67. doi: 10.1002/jcp.21932.

PMID:
19780039
12.

Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression.

Williams C, Helguero L, Edvardsson K, Haldosén LA, Gustafsson JA.

Breast Cancer Res. 2009;11(3):R26. doi: 10.1186/bcr2256. Epub 2009 May 8.

13.

Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells.

Li Y, Bäckesjö CM, Haldosén LA, Lindgren U.

Eur J Pharmacol. 2009 May 1;609(1-3):13-8. doi: 10.1016/j.ejphar.2009.03.004. Epub 2009 Mar 11.

PMID:
19285066
14.

Different roles of estrogen receptors alpha and beta in the regulation of E-cadherin protein levels in a mouse mammary epithelial cell line.

Helguero LA, Lindberg K, Gardmo C, Schwend T, Gustafsson JA, Haldosén LA.

Cancer Res. 2008 Nov 1;68(21):8695-704. doi: 10.1158/0008-5472.CAN-08-0788.

15.

Species difference exists in the effects of 1alpha,25(OH)(2)D(3) and its analogue 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D(3) (2MD) on osteoblastic cells.

Li Y, Bäckesjö CM, Haldosén LA, Lindgren U.

J Steroid Biochem Mol Biol. 2008 Nov;112(1-3):110-6. doi: 10.1016/j.jsbmb.2008.09.004. Epub 2008 Sep 11.

PMID:
18832035
16.

Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.

Bäckesjö CM, Li Y, Lindgren U, Haldosén LA.

Cells Tissues Organs. 2009;189(1-4):93-7. doi: 10.1159/000151744. Epub 2008 Aug 28.

PMID:
18728353
17.

IL-6 receptor expression and IL-6 effects change during osteoblast differentiation.

Li Y, Bäckesjö CM, Haldosén LA, Lindgren U.

Cytokine. 2008 Aug;43(2):165-73. doi: 10.1016/j.cyto.2008.05.007. Epub 2008 Jun 13.

PMID:
18555695
18.
19.

Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.

Bäckesjö CM, Li Y, Lindgren U, Haldosén LA.

J Bone Miner Res. 2006 Jul;21(7):993-1002.

20.

DAX-1 expression is regulated during mammary epithelial cell differentiation.

Helguero LA, Hedengran Faulds M, Förster C, Gustafsson JA, Haldosén LA.

Endocrinology. 2006 Jul;147(7):3249-59. Epub 2006 Apr 20.

PMID:
16627587
21.

Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A.

Olsen H, Haldosén LA.

Exp Cell Res. 2006 May 1;312(8):1371-80. Epub 2006 Feb 2.

PMID:
16457814
22.
23.

Reflections on the discovery and significance of estrogen receptor beta.

Koehler KF, Helguero LA, Haldosén LA, Warner M, Gustafsson JA.

Endocr Rev. 2005 May;26(3):465-78. Epub 2005 Apr 27. Review.

PMID:
15857973
24.

Estrogen receptor functional activity changes during differentiation of mammary epithelial cells.

Faulds MH, Olsen H, Helguero LA, Gustafsson JA, Haldosén LA.

Mol Endocrinol. 2004 Feb;18(2):412-21. Epub 2003 Nov 6.

PMID:
14605098
25.

Effects of 1alpha,25-dihydroxyvitamin D3 and growth hormone on apoptosis and proliferation in UMR 106 osteoblast-like cells.

Morales O, Samuelsson MK, Lindgren U, Haldosén LA.

Endocrinology. 2004 Jan;145(1):87-94. Epub 2003 Oct 2.

PMID:
14525911
27.

Effects of hyperactive Janus kinase 2 signaling in mammary epithelial cells.

Olsen H, Hedengran Faulds MA, Saharinen P, Silvennoinen O, Haldosén LA.

Biochem Biophys Res Commun. 2002 Aug 9;296(1):139-44.

PMID:
12147240
30.

Cross-talk between ERs and signal transducer and activator of transcription 5 is E2 dependent and involves two functionally separate mechanisms.

Faulds MH, Pettersson K, Gustafsson JA, Haldosén LA.

Mol Endocrinol. 2001 Nov;15(11):1929-40.

PMID:
11682624
31.

Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells.

Morales O, Lindgren U, Haldosén LA.

J Bone Miner Res. 2000 Nov;15(11):2284-90.

32.

Extracellular signal-regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a.

Pircher TJ, Petersen H, Gustafsson JA, Haldosén LA.

Mol Endocrinol. 1999 Apr;13(4):555-65.

PMID:
10194762
33.

EGF modulates expression of STAT5 in mammary epithelial cells.

Petersen H, Haldosén LA.

Exp Cell Res. 1998 Sep 15;243(2):347-58.

PMID:
9743594
34.

In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2.

Flores-Morales A, Pircher TJ, Silvennoinen O, Gustafsson JA, Sanchez-Gomez M, Norstedt G, Haldosén LA, Wood TJ.

Mol Cell Endocrinol. 1998 Mar 16;138(1-2):1-10.

PMID:
9685210
35.

Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.

Fernández L, Flores-Morales A, Lahuna O, Sliva D, Norstedt G, Haldosén LA, Mode A, Gustafsson JA.

Endocrinology. 1998 Apr;139(4):1815-24.

PMID:
9528967
36.

Mitogen-activated protein kinase kinase inhibition decreases growth hormone stimulated transcription mediated by STAT5.

Pircher TJ, Flores-Morales A, Mui AL, Saltiel AR, Norstedt G, Gustafsson JA, Haldosén LA.

Mol Cell Endocrinol. 1997 Oct 20;133(2):169-76.

PMID:
9406863
37.

Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter.

Wood TJ, Sliva D, Lobie PE, Goullieux F, Mui AL, Groner B, Norstedt G, Haldosén LA.

Mol Cell Endocrinol. 1997 Jun 20;130(1-2):69-81.

PMID:
9220023
38.

Stimulation of kinase cascades by growth hormone: a paradigm for cytokine signaling.

Wood TJ, Haldosén LA, Sliva D, Sundsthöm M, Norstedt G.

Prog Nucleic Acid Res Mol Biol. 1997;57:73-94. Review. No abstract available.

PMID:
9175431
39.

Constitutive nuclear localization of Janus kinases 1 and 2.

Lobie PE, Ronsin B, Silvennoinen O, Haldosén LA, Norstedt G, Morel G.

Endocrinology. 1996 Sep;137(9):4037-45.

PMID:
8756581
40.

STAT-like DNA-binding activity in Spodoptera frugiperda cells.

Sliva D, Haldosén LA.

Biochem Biophys Res Commun. 1996 Aug 14;225(2):562-9.

PMID:
8753801
41.

Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity.

Gouilleux F, Pallard C, Dusanter-Fourt I, Wakao H, Haldosen LA, Norstedt G, Levy D, Groner B.

EMBO J. 1995 May 1;14(9):2005-13.

42.

Mediation of growth hormone-dependent transcriptional activation by mammary gland factor/Stat 5.

Wood TJ, Sliva D, Lobie PE, Pircher TJ, Gouilleux F, Wakao H, Gustafsson JA, Groner B, Norstedt G, Haldosén LA.

J Biol Chem. 1995 Apr 21;270(16):9448-53.

43.

Growth hormone pretranslationally regulates the sexually dimorphic expression of the prolactin receptor gene in rat liver.

Robertson JA, Haldosén LA, Wood TJ, Steed MK, Gustafsson JA.

Mol Endocrinol. 1990 Aug;4(8):1235-9.

PMID:
2293027
44.

Binding and cross-linking of iodinated rat prolactin to rat hepatic prolactin receptor.

Haldosén LA, Gustafsson JA.

Mol Cell Endocrinol. 1990 May 28;71(1):41-8.

PMID:
2365133
45.

Detection of glycosylated growth hormone-binding proteins in rat serum.

Haldosén LA, Gustafsson JA.

Mol Cell Endocrinol. 1990 Jan 22;68(2-3):187-94.

PMID:
2311824
46.
47.
48.
49.

Characterization of the somatogenic receptor in rat liver. Hydrodynamic properties and affinity cross-linking.

Husman B, Haldosén LA, Andersson G, Gustafsson JA.

J Biol Chem. 1988 Mar 15;263(8):3963-70.

50.

Characterization of hepatic lactogen receptor. Subunit composition and hydrodynamic properties.

Haldosén LA, Gustafsson JA.

J Biol Chem. 1987 May 25;262(15):7404-11.

Supplemental Content

Loading ...
Support Center